Cycclone(OTC) CDBT

Current PriceN/A

Market CapN/A

Since IPO (2008)-98%

5 Year-62%

1 Year+8%

1 Month-28%

Cycclone last closing stock price
Metric	Price	Date
Last close	USD 0.04	2026-07-21

Cycclone stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-11.84%	USD 0.05	2026-07-08
1 month	-28%	USD 0.06	2026-06-18
3 month	+19.01%	USD 0.04	2026-04-21
Year to date	+10.77%	USD 0.04	2025-12-31
1 year	+8%	USD 0.04	2025-07-18
3 year	-41.62%	USD 0.07	2023-07-21
5 year	-62.43%	USD 0.12	2021-07-22
Since inception	-97.84%	USD 2.00	2008-02-13

Cycclone Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$355.37K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

CDBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cycclone

China Dasheng Biotechnology Company specializes in the development and distribution of microbial products in China. The company focuses on enhancing agricultural and livestock productivity through innovative microbial solutions.

Products and Services

Microbial additives for livestock feed
Biological preservatives for agricultural produce
Bacteria-based fertilizers for crops

Growth Outlook

Significant demand for sustainable agricultural solutions is rising
Investment in biotechnology is expected to increase in the coming years
Expansion into real estate may diversify revenue streams

Financial Highlights

Trailing twelve months (TTM) P/E ratio stands at 2.32
Return on equity (ROE) is reported at 25.67%
Net income for the latest quarter was -$74,137

China Dasheng Biotechnology Company operates in a niche market with a focus on microbial solutions that enhance agricultural productivity. The company's innovative products aim to improve livestock feed quality and crop yields, addressing the growing demand for sustainable agricultural practices. The recent financial data indicates a low P/E ratio, suggesting potential undervaluation, while a strong ROE reflects effective management of equity. Despite recent net losses, the company's strategic investments in biotechnology and real estate may provide avenues for future growth and diversification.

AI Generated • Jul 17, 2026

Industry

Chemicals

Sector

Materials

CEO

Michael P. Nugent

Website

www.chinadashengbio.com

Headquarters

Lanzhou, CN

CDBT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

2566.85%

Return on Capital

N/A

Return on Assets

1138.13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$28.69K

Operating Income

-$236.33K

EBITDA

-$260.27K

Operating Cash Flow

-$250.21K

Capital Expenditure

-$152.29

Free Cash Flow

-$250.36K

Cash & ST Invst.

$112.48K

Total Debt

$1.10M

Cycclone Performance Analysis

Cycclone annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2025	2025-06-30	USD 0	N/A

Cycclone sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2023-12-31	N/A
Q3	2024-03-31	N/A
Q1	2024-09-30	N/A
Q2	2024-12-31	N/A

Cycclone annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2025	2025-06-30	USD 0.00	N/A

Cycclone sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2023-12-31	31.2%
Q3	2024-03-31	21.2%
Q1	2024-09-30	N/A
Q2	2024-12-31	-80.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$15.26K

-135.1%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

689

N/A

Net Income

-$74.14K

+62.7%

EBITDA

-$58.87K

+60.0%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Total Cash

$112.48K

-1.5%

Total Debt

$1.10M

+0.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.10M

+0.8%

Return on Assets

11.38%

N/A

Return on Invested Capital

49.89%

N/A

Free Cash Flow

-$58.49K

-102.0%

Operating Cash Flow

-$58.49K

-102.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GDVMGlobal Developments, Inc.

GDVMGlobal Developments, Inc.$0.01-1.59%

ASNBEKIMAS Corporation

ASNBEKIMAS Corporation$0.85+6.58%

PGIDPeregrine Industries, Inc.

PGIDPeregrine Industries, Inc.$0.00-60.00%

FDOCFuel Doctor Holdings, Inc.

FDOCFuel Doctor Holdings, Inc.$0.27-99.33%

PROPPrairie Operating Co.

PROPPrairie Operating Co.$0.80-0.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

TAT&T

TAT&T$24.13+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

STAKStak

STAKStak$9.27+6.02%

Questions About CDBT

What is the current price of Cycclone?

Cycclone is trading at N/A per share.

What is the 52-week range for Cycclone?

Over the past 52 weeks, Cycclone has traded between N/A and N/A.

How much debt does Cycclone have?

As of the most recent reporting period, Cycclone reported total debt of $43.85K.

How much cash does Cycclone have on hand?

Cycclone reported $200.00 in cash and cash equivalents in its most recent financial results.

What is Cycclone’s dividend yield?

Cycclone does not currently have a dividend yield.

Cycclone(OTC) CDBT

Cycclone Financials at a Glance

CDBT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cycclone

CDBT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cycclone Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CDBT

What is the current price of Cycclone?

What is the 52-week range for Cycclone?

How much debt does Cycclone have?

How much cash does Cycclone have on hand?

What is Cycclone’s dividend yield?

Premium Investing Services